The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

OLMA FINANCIAL STATEMENTS

Olema Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

OLMAOlema Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-306 K $ · -Infinity%Operating Income-221.1 M $ · -Infinity%Pre-tax Income-204.6 M $ · -Infinity%Net Income to Owners-204.6 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-306 K $—
Operating Income-221.1 M $—
EBITDA-208.2 M $—
Net Income to Owners-204.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets486.6 M
  • Equity430.6 M $88%
  • Current Liabilities53 M $11%
  • Long-term Liabilities3 M $1%

Key Figures

YoY change
Total Assets486.6 M $+27.4%
Total Liabilities56 M $+52.4%
Total Equity430.6 M $+24.7%
Cash & ST Investments461.1 M $+27.4%
Total Debt660 K $-86.1%
Net Debt-47.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-164.7 M $Operating-99.5 M $Investing260.4 M $Financing-3.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-164.7 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-164.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OLMA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.